相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
T. Kobayashi et al.
LEUKEMIA (2010)
IL-17 contributes to CD4-mediated graft-versus-host disease
Lucy W. Kappel et al.
BLOOD (2009)
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease
Tangsheng Yi et al.
BLOOD (2009)
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Michael J. Carlson et al.
BLOOD (2009)
Galectin-9 Significantly Prolongs the Survival of Fully Mismatched Cardiac Allografts in Mice
Wentao He et al.
TRANSPLANTATION (2009)
Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
Masako Seki et al.
CLINICAL IMMUNOLOGY (2008)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft
Feng Wang et al.
CELLULAR IMMUNOLOGY (2007)
Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17
Susumu Nakae et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Vu H. Nguyen et al.
BLOOD (2007)
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis
Keiji Hirota et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis
Till A. Roehn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease
Jose L. Cohen et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
B Blanco et al.
BLOOD (2006)
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
Y Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Galectin-9 induces maturation of human monocyte-derived dendritic cells
SY Dai et al.
JOURNAL OF IMMUNOLOGY (2005)
Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation
MH Albert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer
A Irie et al.
CLINICAL CANCER RESEARCH (2005)
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation
A Gerbitz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway
Y Kashio et al.
JOURNAL OF IMMUNOLOGY (2003)
Regulation of galectin-9 expression and release in Jurkat T cell line cells
S Chabot et al.
GLYCOBIOLOGY (2002)
Galectin-9 in physiological and pathological conditions
M Hirashima et al.
GLYCOCONJUGATE JOURNAL (2002)
分享论文
